Suppr超能文献

LDL particle size: an important drug target?

作者信息

Rajman I, Eacho P I, Chowienczyk P J, Ritter J M

机构信息

Clinical Pharmacology, Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Windlesham, UK.

出版信息

Br J Clin Pharmacol. 1999 Aug;48(2):125-33. doi: 10.1046/j.1365-2125.1999.00991.x.

Abstract
摘要

相似文献

1
LDL particle size: an important drug target?低密度脂蛋白颗粒大小:一个重要的药物靶点?
Br J Clin Pharmacol. 1999 Aug;48(2):125-33. doi: 10.1046/j.1365-2125.1999.00991.x.
2
Low-density lipoprotein particle composition: what is the contribution to atherogenicity?
Curr Opin Lipidol. 2000 Jun;11(3):227-8. doi: 10.1097/00041433-200006000-00001.
4
Particle size: the key to the atherogenic lipoprotein?
QJM. 1994 Dec;87(12):709-20. doi: 10.1093/oxfordjournals.qjmed.a068888.

引用本文的文献

本文引用的文献

3
PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes.
Atherosclerosis. 1998 Apr;137 Suppl:S75-80. doi: 10.1016/s0021-9150(97)00315-8.
7
Selective imidazoline receptor agonists for metabolic syndrome.
Lancet. 1998 Jan 17;351(9097):152-3. doi: 10.1016/S0140-6736(98)22003-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验